Taevas
South KoreaMedical Devices
Product Registration
Market Access for Product-Registration in South Korea
Navigating the intricate landscape of global product registration requires a robust market access strategy. Taevas Life Sciences provides comprehensive solutions to ensure your product not only gains regulatory approval but also achieves optimal market pe
Market
Global
Industry
Product-Registration
Regulator
Diverse National Regulatory Bodies (e.g., EMA, FDA, PMDA, NMPA)
Timeline
8-16 weeks (initial strategy phase)
Deliverables
Global Market Access Strategy, Pricing Models, HTA Dossier Support, Reimbursement Roadmaps
What We Deliver
6 Pillars of Market Access
Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.
01
Regulatory Intelligence & Strategy
Deep dive into country-specific regulatory requirements, submission processes, and approval timelines to build a compliant and efficient registration pathway.
Country-specific regulatory landscape analysis
Submission strategy optimization
How It Works
How It Works
A structured engagement — typically delivered in a few weeks.
Step 1 · Week 1-2
Discovery & Landscape Analysis
Comprehensive review of your product, target markets, existing data, and the global regulatory and market access environment.
Market Snapshot
Market Overview: Global + Product-Registration
Increasing Regulatory Complexity
The global regulatory landscape is continuously evolving, with heightened scrutiny on clinical evidence, real-world data, and health economic outcomes, necessitating sophisticated strategic planning.
HTA's Growing Influence
Health Technology Assessment bodies are playing an increasingly pivotal role in market access decisions globally, demanding robust evidence packages that demonstrate both clinical efficacy and cost-effectiveness.
What's Included
Deliverables
A structured, decision-ready package of deliverables.
Global Market Access Strategy Report
A comprehensive document outlining market entry strategies, HTA considerations, pricing corridors, and reimbursement pathways for target countries.
Targeted HTA & P&R Dossier Support
Strategic guidance and content development support for HTA submissions and pricing/reimbursement dossiers, tailored to specific national requirements.
Stakeholder Engagement & Advocacy Plan
A detailed plan for identifying and engaging key opinion leaders, patient groups, and payers to build support and facilitate product adoption.
Regulatory & Market Intelligence Briefs
Regular updates and analyses on changes in the global regulatory environment, competitor activities, and evolving market access trends.
Who This Is For
Use Cases
Market Entry
Accelerating a Novel Biologic's Global Launch
A biotech company with a groundbreaking biologic faced fragmented regulatory pathways and diverse HTA requirements across Europe and Asia. Taevas developed a harmonized evidence generation and market access strategy.
Outcome
Achieved faster regulatory approvals and favorable reimbursement decisions in multiple key markets.
Next Steps
Related Services
FAQ
Frequently Asked Questions
Get Started
Ready to Start Market Access in Global?
Partner with Taevas Life Sciences to transform complex global registration hurdles into clear market opportunities. Our expertise ensures your product achieves regulatory success and optimal market penetration.
Expedited Global Registrations
Maximized Market Penetration
Optimized ROI on R&D Investments
Reduced Market Access Risks